This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Multicenter Study

. 2015 Apr;172(4):1128-31.

doi: 10.1111/bjd.13521. Epub 2015 Mar 6.

BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma

Z García-Casado¹, V Traves, J Bañuls, M Niveiro, E Gimeno-Carpio, A I Jimenez-Sanchez, M Moragón, J A Onrubia, V Oliver, R Kumar, E Nagore

Affiliations

PMID: 25385688
DOI: 10.1111/bjd.13521

Multicenter Study

BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma

Z García-Casado et al. Br J Dermatol. 2015 Apr.

. 2015 Apr;172(4):1128-31.

doi: 10.1111/bjd.13521. Epub 2015 Mar 6.

Authors

Z García-Casado¹, V Traves, J Bañuls, M Niveiro, E Gimeno-Carpio, A I Jimenez-Sanchez, M Moragón, J A Onrubia, V Oliver, R Kumar, E Nagore

Affiliation

¹ Laboratory of Molecular Biology, Instituto Valenciano de Oncología, Valencia, Spain.

PMID: 25385688
DOI: 10.1111/bjd.13521

No abstract available

PubMed Disclaimer

Similar articles

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.
Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group. Thomas NE, et al. J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24. J Invest Dermatol. 2017. PMID: 28842324 Free PMC article.
NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
Hacker E, Nagore E, Cerroni L, Woods SL, Hayward NK, Chapman B, Montgomery GW, Soyer HP, Whiteman DC. Hacker E, et al. J Invest Dermatol. 2013 Apr;133(4):1027-33. doi: 10.1038/jid.2012.385. Epub 2012 Oct 25. J Invest Dermatol. 2013. PMID: 23096702
BRAF and MC1R in melanoma: different in head and neck tumors?
Fink EC, Fisher DE. Fink EC, et al. J Invest Dermatol. 2013 Apr;133(4):878-80. doi: 10.1038/jid.2012.475. J Invest Dermatol. 2013. PMID: 23486431
Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta-analysis.
Zanna I, Caini S, Raimondi S, Saieva C, Masala G, Massi D, Cocorocchio E, Queirolo P, Stanganelli I, Gandini S. Zanna I, et al. Mol Carcinog. 2021 Mar;60(3):167-171. doi: 10.1002/mc.23280. Epub 2021 Jan 14. Mol Carcinog. 2021. PMID: 33444485 Review.
Functional interplay between secreted ligands and receptors in melanoma.
Herraiz C, Jiménez-Cervantes C, Sánchez-Laorden B, García-Borrón JC. Herraiz C, et al. Semin Cell Dev Biol. 2018 Jun;78:73-84. doi: 10.1016/j.semcdb.2017.06.021. Epub 2017 Jul 1. Semin Cell Dev Biol. 2018. PMID: 28676423 Review.

See all similar articles

Cited by

Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.
Filipović N, Šitum M, Buljan M. Filipović N, et al. Dermatol Pract Concept. 2021 Apr 12;11(2):e2021040. doi: 10.5826/dpc.1102a40. eCollection 2021 Mar. Dermatol Pract Concept. 2021. PMID: 33954019 Free PMC article. Review.
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.
Bruno W, Martinuzzi C, Dalmasso B, Andreotti V, Pastorino L, Cabiddu F, Gualco M, Spagnolo F, Ballestrero A, Queirolo P, Grillo F, Mastracci L, Ghiorzo P. Bruno W, et al. Oncotarget. 2017 Dec 14;9(5):5691-5702. doi: 10.18632/oncotarget.23204. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464027 Free PMC article.
Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
Espinosa P, Pfeiffer RM, García-Casado Z, Requena C, Landi MT, Kumar R, Nagore E. Espinosa P, et al. Eur J Cancer. 2016 Jan;53:115-24. doi: 10.1016/j.ejca.2015.10.058. Epub 2015 Dec 17. Eur J Cancer. 2016. PMID: 26702765 Free PMC article.
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.
Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group. Thomas NE, et al. J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24. J Invest Dermatol. 2017. PMID: 28842324 Free PMC article.
BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.
Hugdahl E, Kalvenes MB, Puntervoll HE, Ladstein RG, Akslen LA. Hugdahl E, et al. Br J Cancer. 2016 Mar 29;114(7):801-8. doi: 10.1038/bjc.2016.44. Epub 2016 Feb 25. Br J Cancer. 2016. PMID: 26924424 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal